Clinical Trial Update: Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity [NA]

View source ↗

Summary

A clinical trial investigates whether antagonizing the ghrelin receptor affects brain responses to food cues in obesity; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GHS-R antagonist (ghrelin receptor antagonist)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Obesity and Overweight | NA | Status: NOT_YET_RECRUITING